ArticleClinical pharmacology and therapeutics2025

Pharmacokinetic, Safety, and Pharmacodynamic Profiles of Saroglitazar Magnesium in Cholestatic Cirrhosis With Hepatic Impairment and Participants With Renal Impairment.

Raj Vuppalanchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.